Characteristics | PS/non-PS | ||
---|---|---|---|
Studies | Mean difference (95% CI) | Heterogeneity | |
Baseline information | |||
Male | 4/5 | 0.94 [0.65,1.35]; P=0.73/1.83 [1.43, 2.34]; P<0.01 | I2=0%; P=0.91/I2=13%; P=0.33 |
Age | 4/3 | 2.66 [0.96, 4.36]; P=0.002/6.21 [4.24, 8.19]; P<0.01 | I2=25%; P=0.26/I2=57%; P=0.10 |
BMI | 4/4 | −0.13 [−0.60, 0.34]; P=0.58/0.21 [−0.16, 0.58]; P=0.26 | I2=0%; P=0.98/I2=38%; P=0.18 |
T1-T2 | 3/4 | 2.04 [0.40, 10.28]; P=0.39/1.79 [0.30, 10.74]; P=0.53 | I2=0%; P=0.49/I2=65%; P=0.04 |
T3-T4 | 3/4 | 0.49 [0.10, 2.48]; P=0.39/0.56 [0.09, 3.37]; P=0.53 | I2=0%; P=0.49/I2=65%; P=0.04 |
Surgical methods and reconstruction methods | |||
TG | 2/2 | 1.56 [0.42, 5.88]; P=0.51/0.87 [0.53, 1.44]; P=0.60 | I2=0%; P=0.98/I2=0%; P=0.72 |
SG | 2/2 | 0.64 [0.17, 2.41]; P=0.51/1.14 [0.72, 1.80]; P=0.58 | I2=0%; P=0.98/I2=0%; P=0.73 |
B-I or B-II | 2/2 | 0.91 [0.55, 1.52]; P=0.72/1.13[0.31, 4.09]; P=0.85 | I2=0%; P=0.84/I2=77%; P=0.04 |
Roux-en-Y | 2/2 | 1.10 [0.66, 1.83]; P=0.72/0.96 [0.30, 3.04]; P=0.94 | I2=0%; P=0.84/I2=67%; P=0.08 |
Short-term outcomes | |||
Blood loss | 2/4 | 12.97 [−60.39, 86.34]; P=0.73/−6.44 [−17.08, 4.20]; P=0.24 | I2=91%; P=0.0007/I2=11%; P=0.34 |
Operation time | 3/4 | −5.27 [−13.08, 2.55]; P=0.19/−6.48[−13.02, 0.06]; P=0.05 | I2=0%; P=0.39/I2=24%; P=0.27 |
Retrieved LNs | 3/3 | −2.33 [−7.87, 3.21]; P=0.41/−3.14 [−5.01, −1.27]; P=0.001 | I2=82%; P=0.004/I2=0%; P=0.70 |
Metastatic LNs | 4/3 | 0.96 [0.50, 1.81]; P=0.89/0.52 [0.30, 0.92]; P=0.02 | I2=0%; P=0.62/I2=12%; P=0.32 |
PHS | 2/4 | 0.60 [−1.25,2.45]; P=0.52/0.53 [−0.37, 1.43]; P=0.25 | I2=0%; P=1.00/I2=0%; P=0.95 |
Postoperative complications | |||
Overall | 4/5 | 1.25 [0.81, 1.92]; P=0.32/1.11[0.80, 1.54]; P=0.53 | I2=0%; P=0.75/I2=15%; P=0.32 |
AL | 3/4 | 1.18 [0.22, 6.28]; P=0.84/1.21 [0.49, 2.97]; P=0.68 | I2=0%; P=0.77/I2=0%; P=0.45 |
AS | 2/2 | 2.27 [0.59, 8.74]; P=0.24/0.86 [0.23, 3.28]; P=0.83 | I2=0%; P=0.49/I2=0%; P=0.92 |
Ileus | 2/5 | 1.90 [0.45, 8.01]; P=0.38/ 1.66 [0.85, 3.25]; P=0.14 | I2=0%; P=0.72/I2=39%; P=0.16 |
Abdominal infection | 2/3 | 0.46 [0.05, 4.47]; P=0.50/2.06 [0.87, 4.87]; P=0.10 | I2=0%; P=0.76/I2=0%; P=0.61 |
Gastric stasis | 2/3 | 0.60 [0.15, 2.36]; P=0.47/0.79 [0.27, 2.28]; P=0.66 | I2=0%; P=0.38/I2=0%; P=0.98 |
Wound infection | 3/3 | 2.31 [0.78, 6.86]; P=0.13/1.33[0.53, 3.36]; P=0.55 | I2=0%; P=0.65/I2=0%; P=0.96 |
PL | 3/2 | 2.17 [0.59, 7.97]; P=0.24/0.80 [0.23, 2.77]; P=0.72 | I2=0%; P=0.37/I2=9%; P=0.29 |
PB | 2/2 | 0.71 [0.18, 2.81]; P=0.63/0.67 [0.12, 3.59]; P=0.64 | I2=0%; P=0.96/I2=0%; P=0.91 |